title: The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities.
abstract: Heparin affin regulatory peptide (HARP) is a 18-kDa heparin-binding polypeptide that is highly expressed in developing tissues and in several primary human tumors. It seems to play a key role in cellular growth and differentiation. In vitro, HARP displays mitogenic, angiogenic, and neurite outgrowth activities. It is a secreted protein that is organized in two beta-sheet domains, each domain containing a cluster of basic residues. To assess determinants involved in the biological activities of HARP, C-terminally truncated proteins were produced in Chinese hamster ovary-K1 cells and tested for their mitogenic, tumor formation in nude mice and neurite outgrowth activities. Our data clearly indicate that the residues 111-136 of the lysine-rich C-terminal domain are involved in the mitogenic and tumor formation activities of HARP. Correlatively, no signal transduction was detected using the corresponding mutant, suggesting the absence of HARP binding to its high affinity receptor. However, this C-terminal domain of HARP is not involved in the neurite outgrowth activity. We also demonstrate that HARP signal peptide cleavage could led to two maturated forms that are both but differentially mitogenic.
authors.affiliation: Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires, CNRS UPRES-A 7053, Université Paris XII, Avenue du Général de Gaulle, 94010 Créteil Cedex, France.
authors.forename: I
authors.initials: I
authors.lastname: Bernard-Pierrot
authors.forename: J
authors.initials: J
authors.lastname: Delbe
authors.forename: D
authors.initials: D
authors.lastname: Caruelle
authors.forename: D
authors.initials: D
authors.lastname: Barritault
authors.forename: J
authors.initials: J
authors.lastname: Courty
authors.forename: P E
authors.initials: PE
authors.lastname: Milhiet
mesh_terms: D016475:3T3 Cells; D000818:Animals; D016466:CHO Cells; D002273:Carcinogens / Q000494:pharmacology*; D002352:Carrier Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D006224:Cricetinae; D016207:Cytokines / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008934:Mitogens / Q000502:physiology*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D002273:Carcinogens; D002352:Carrier Proteins; D016207:Cytokines; D008934:Mitogens; D011994:Recombinant Proteins; C066845:pleiotrophin